CliffBio

Axsome Therapeutics

Patent cliffs & loss of exclusivity

Axome Therapeutics is a New York-based biopharmaceutical company developing therapies for central nervous system disorders.

Company

AngelList URLhttps://angel.co/axsome-therapeutics
CAGE Code7J7H1
Legal NameAxsome Therapeutics, Inc.
Company Operating StatusActive
Contact Page URLhttps://www.axsome.com/contact-us
Crunchbase URLhttps://www.crunchbase.com/organization/axsome-therapeutics
Email format{f}{last}
Fax Number+1 (212) 320-0245

3 upcoming patent cliffs

DrugIngredientTypeCliff
  1. AUVELITYBUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDESmall mol.Jan 2043
  2. AUVELITYBUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDESmall mol.Nov 2043
  3. SYMBRAVOMELOXICAM; RIZATRIPTAN BENZOATESmall mol.Mar 2045

Loss-of-exclusivity dates are derived from the FDA Orange & Purple Books; company detail is from the CliffBio graph. Estimates are projections, not legal advice.